rs535860
Variant names:
Variant summary
Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_ModerateBA1
The NM_012104.6(BACE1):c.*404T>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.119 in 197,860 control chromosomes in the GnomAD database, including 1,428 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.12 ( 1110 hom., cov: 32)
Exomes 𝑓: 0.11 ( 318 hom. )
Consequence
BACE1
NM_012104.6 3_prime_UTR
NM_012104.6 3_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 2.34
Publications
13 publications found
Genes affected
BACE1 (HGNC:933): (beta-secretase 1) This gene encodes a member of the peptidase A1 family of aspartic proteases. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed to generate the mature protease. This transmembrane protease catalyzes the first step in the formation of amyloid beta peptide from amyloid precursor protein. Amyloid beta peptides are the main constituent of amyloid beta plaques, which accumulate in the brains of human Alzheimer's disease patients. [provided by RefSeq, Nov 2015]
BACE1-AS (HGNC:37125): (BACE1 antisense RNA) This gene encodes an unspliced long non-coding RNA transcribed from the opposite strand to BACE1. The encoded transcript is thought to form an RNA duplex with BACE1 mRNA thereby regulating its expression and is also thought to promote post-transcriptional feed-forward regulation of BACE1. This may lead to increased levels of beta amyloid and increased senile plaque deposition, and therefore may play a role in the pathophysiology of Alzheimer's disease. [provided by RefSeq, Jan 2015]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -10 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.33).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.119 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| BACE1 | NM_012104.6 | c.*404T>A | 3_prime_UTR_variant | Exon 9 of 9 | ENST00000313005.11 | NP_036236.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| BACE1 | ENST00000313005.11 | c.*404T>A | 3_prime_UTR_variant | Exon 9 of 9 | 1 | NM_012104.6 | ENSP00000318585.6 |
Frequencies
GnomAD3 genomes AF: 0.122 AC: 18506AN: 152060Hom.: 1106 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
18506
AN:
152060
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.109 AC: 4966AN: 45682Hom.: 318 Cov.: 0 AF XY: 0.109 AC XY: 2556AN XY: 23478 show subpopulations
GnomAD4 exome
AF:
AC:
4966
AN:
45682
Hom.:
Cov.:
0
AF XY:
AC XY:
2556
AN XY:
23478
show subpopulations
African (AFR)
AF:
AC:
292
AN:
2474
American (AMR)
AF:
AC:
483
AN:
3922
Ashkenazi Jewish (ASJ)
AF:
AC:
171
AN:
1122
East Asian (EAS)
AF:
AC:
357
AN:
3932
South Asian (SAS)
AF:
AC:
449
AN:
4238
European-Finnish (FIN)
AF:
AC:
218
AN:
1684
Middle Eastern (MID)
AF:
AC:
20
AN:
140
European-Non Finnish (NFE)
AF:
AC:
2733
AN:
25934
Other (OTH)
AF:
AC:
243
AN:
2236
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.513
Heterozygous variant carriers
0
212
423
635
846
1058
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
62
124
186
248
310
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.122 AC: 18520AN: 152178Hom.: 1110 Cov.: 32 AF XY: 0.122 AC XY: 9085AN XY: 74388 show subpopulations
GnomAD4 genome
AF:
AC:
18520
AN:
152178
Hom.:
Cov.:
32
AF XY:
AC XY:
9085
AN XY:
74388
show subpopulations
African (AFR)
AF:
AC:
5053
AN:
41512
American (AMR)
AF:
AC:
1762
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
AC:
566
AN:
3472
East Asian (EAS)
AF:
AC:
450
AN:
5178
South Asian (SAS)
AF:
AC:
534
AN:
4822
European-Finnish (FIN)
AF:
AC:
1541
AN:
10600
Middle Eastern (MID)
AF:
AC:
43
AN:
294
European-Non Finnish (NFE)
AF:
AC:
8237
AN:
67986
Other (OTH)
AF:
AC:
244
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
823
1646
2470
3293
4116
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
204
408
612
816
1020
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
308
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.